We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amphastar, Watson Renew Appeal to Lift Generic Lovenox Ban
Amphastar, Watson Renew Appeal to Lift Generic Lovenox Ban
December 6, 2011
Amphastar and Watson Pharmaceuticals are again appealing a federal court’s decision to uphold an injunction barring them from selling generic versions of Sanofi’s blockbuster blood-thinner Lovenox.